CEACAM1 | Carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) | CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/2146/5909_B_2_1_rna_selected_60x60.jpg) | Tissue enhanced |
CEACAM5 | Carcinoembryonic antigen-related cell adhesion molecule 5 | Cancer-related genes CD markers Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/21/18_B_7_1_rna_selected_60x60.jpg) | Tissue enhanced |
CEACAM6 | Carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) | Cancer-related genes CD markers Predicted intracellular proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/11041/27138_B_8_3_rna_selected_60x60.jpg) | Group enriched |
CEACAM7 | Carcinoembryonic antigen-related cell adhesion molecule 7 | Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/69621/152549_A_5_7_rna_selected_60x60.jpg) | Group enriched |
CES3 | Carboxylesterase 3 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | ![](/images/41307/490_E12_2_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/41307/91314_B_8_4_rna_selected_60x60.jpg) | Tissue enhanced |
CLCA1 | Chloride channel accessory 1 | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/52787/ihc_cell_selected_60x60.jpg) | ![](/images/59301/139587_B_5_1_rna_selected_60x60.jpg) | Group enriched |
CLDN18 | Claudin 18 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/13243/28311_B_2_5_rna_selected_60x60.jpg) | Group enriched |
CLDN3 | Claudin 3 | Cancer-related genes Disease related genes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/14361/33700_B_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
CPS1 | Carbamoyl-phosphate synthase 1, mitochondrial | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted intracellular proteins
| | ![](/images/21400/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/3781/10124_B_8_6_rna_selected_60x60.jpg) | Group enriched |
CTSE | Cathepsin E | Enzymes Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/12940/129727_B_1_8_rna_selected_60x60.jpg) | Group enriched |
CYP2C19 | Cytochrome P450, family 2, subfamily C, polypeptide 19 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/15066/34421_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
CYP2D6 | Cytochrome P450, family 2, subfamily D, polypeptide 6 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | ![](/images/45223/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/45223/101840_B_9_3_rna_selected_60x60.jpg) | Group enriched |
CYP3A4 | Cytochrome P450, family 3, subfamily A, polypeptide 4 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/33671/76711_B_9_7_rna_selected_60x60.jpg) | Group enriched |
CYP4F2 | Cytochrome P450, family 4, subfamily F, polypeptide 2 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/58960/133524_B_8_6_rna_selected_60x60.jpg) | Group enriched |
DAB1 | Dab, reelin signal transducer, homolog 1 (Drosophila) | Predicted intracellular proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/52033/139611_B_8_4_rna_selected_60x60.jpg) | Tissue enhanced |
DAZ1 | Deleted in azoospermia 1 | Disease related genes Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/47113/122891_B_8_2_rna_selected_60x60.jpg) | Group enriched |
DDC | Dopa decarboxylase (aromatic L-amino acid decarboxylase) | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | ![](/images/17742/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/17742/39381_B_7_7_rna_selected_60x60.jpg) | Tissue enhanced |
DEFA5 | Defensin, alpha 5, Paneth cell-specific | Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/15775/141535_B_8_1_rna_selected_60x60.jpg) | Group enriched |
DEFA6 | Defensin, alpha 6, Paneth cell-specific | Plasma proteins Predicted secreted proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/19462/140672_B_9_3_rna_selected_60x60.jpg) | Group enriched |
DHDH | Dihydrodiol dehydrogenase (dimeric) | Enzymes Predicted intracellular proteins
| | ![](/images/44131/if_selected_60x60.jpg) | ![](/images/44131/ihc_cell_selected_60x60.jpg) | ![](/images/44131/97426_B_2_6_rna_selected_60x60.jpg) | Tissue enhanced |
DHRS11 | Dehydrogenase/reductase (SDR family) member 11 | Predicted intracellular proteins
| | ![](/images/41226/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/48236/113658_B_1_3_rna_selected_60x60.jpg) | Group enriched |
DMBT1 | Deleted in malignant brain tumors 1 | Disease related genes Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/40778/142067_B_9_7_rna_selected_60x60.jpg) | Group enriched |
DPEP1 | Dipeptidase 1 (renal) | Enzymes FDA approved drug targets Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/9426/25394_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
DPP4 | Dipeptidyl-peptidase 4 | CD markers Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/45970/113237_B_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
DQX1 | DEAQ box RNA-dependent ATPase 1 | Enzymes Predicted intracellular proteins
| | ![](/images/39158/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/39158/156571_B_2_2_rna_selected_60x60.jpg) | Tissue enhanced |
EPCAM | Epithelial cell adhesion molecule | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images/26761/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/26761/56007_A_3_2_rna_selected_60x60.jpg) | Tissue enhanced |
EPS8L1 | EPS8-like 1 | Predicted intracellular proteins Predicted secreted proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/41851/88506_B_5_8_rna_selected_60x60.jpg) | Tissue enhanced |
EXOC3L4 | Exocyst complex component 3-like 4 | Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/43661/97673_B_5_3_rna_selected_60x60.jpg) | Tissue enhanced |
FABP1 | Fatty acid binding protein 1, liver | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/28275/60871_B_9_1_rna_selected_60x60.jpg) | Group enriched |
FABP2 | Fatty acid binding protein 2, intestinal | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | ![](/images/47326/945_D11_2_selected_60x60.jpg) | ![](/images/47325/ihc_cell_selected_60x60.jpg) | ![](/images/47325/104853_B_8_2_rna_selected_60x60.jpg) | Group enriched |
FABP6 | Fatty acid binding protein 6, ileal | Predicted intracellular proteins Predicted secreted proteins
| | ![](/images/12601/1422_F6_1_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/12601/58468_B_9_1_rna_selected_60x60.jpg) | Tissue enriched |
FAM159B | Family with sequence similarity 159, member B | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/11778/32339_B_9_2_rna_selected_60x60.jpg) | Group enriched |
FBP1 | Fructose-1,6-bisphosphatase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | ![](/images/5857/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/5857/18052_A_1_6_rna_selected_60x60.jpg) | Tissue enhanced |
FCGBP | Fc fragment of IgG binding protein | Predicted intracellular proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/3564/11399_B_1_7_rna_selected_60x60.jpg) | Group enriched |
FOLH1 | Folate hydrolase (prostate-specific membrane antigen) 1 | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/1451/ihc_cell_selected_60x60.jpg) | ![](/images/1451/4356_B_1_4_rna_selected_60x60.jpg) | Tissue enhanced |
FUT3 | Fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group) | Blood group antigen proteins Enzymes Predicted intracellular proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/46966/114458_B_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
GAL3ST2 | Galactose-3-O-sulfotransferase 2 | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/71809/155878_B_7_4_rna_selected_60x60.jpg) | Group enriched |
GALNT5 | Polypeptide N-acetylgalactosaminyltransferase 5 | Enzymes Predicted intracellular proteins
| | ![](/images/9035/1368_G5_4_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/8963/24612_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
GALNT6 | Polypeptide N-acetylgalactosaminyltransferase 6 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | ![](/images/17086/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/17086/39520_B_1_3_rna_selected_60x60.jpg) | Tissue enhanced |
GAST | Gastrin | Cancer-related genes Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/38/ihc_cell_selected_60x60.jpg) | ![](/images/38/373_B_1_5_rna_selected_60x60.jpg) | Tissue enriched |
GDA | Guanine deaminase | Enzymes Plasma proteins Predicted intracellular proteins
| | ![](/images/24099/if_selected_60x60.jpg) | ![](/images/24099/ihc_cell_selected_60x60.jpg) | ![](/images/24099/53411_A_7_6_rna_selected_60x60.jpg) | Tissue enhanced |
GHRL | Ghrelin/obestatin prepropeptide | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/14246/155547_A_3_5_selected_60x60.jpg) | ![](/images/14246/143314_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
GIF | Gastric intrinsic factor (vitamin B synthesis) | Disease related genes Predicted secreted proteins
| | ![](/images/40774/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/39908/87834_A_5_5_rna_selected_60x60.jpg) | Tissue enriched |
GIP | Gastric inhibitory polypeptide | Plasma proteins Predicted secreted proteins
| | ![](/images/21612/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/21612/140668_B_8_3_rna_selected_60x60.jpg) | Group enriched |
GKN1 | Gastrokine 1 | Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/47684/108024_A_3_7_selected_60x60.jpg) | ![](/images/47684/142194_B_2_5_rna_selected_60x60.jpg) | Tissue enriched |
GKN2 | Gastrokine 2 | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/57765/ihc_cell_selected_60x60.jpg) | ![](/images/57765/132118_B_3_2_rna_selected_60x60.jpg) | Tissue enriched |
GLRA2 | Glycine receptor, alpha 2 | FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/70422/153647_B_8_8_rna_selected_60x60.jpg) | Group enriched |
GNG13 | Guanine nucleotide binding protein (G protein), gamma 13 | Predicted intracellular proteins RAS pathway related proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/46272/101474_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
GPA33 | Glycoprotein A33 (transmembrane) | Cancer-related genes Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/18858/ihc_cell_selected_60x60.jpg) | ![](/images/18858/43097_B_2_6_rna_selected_60x60.jpg) | Group enriched |
GUCA2A | Guanylate cyclase activator 2A (guanylin) | Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/18215/ihc_cell_selected_60x60.jpg) | ![](/images/18215/141725_B_8_1_rna_selected_60x60.jpg) | Group enriched |